Why the study?
Is ribosomal protein L7 a candidate autoantigen associated with transplant-associated coronary artery disease?
Is ribosomal protein L7 a candidate autoantigen associated with transplant-associated coronary artery disease?
Answers are grounded in this paper and cite their sources.
Ribosomal protein L7 is identified as a candidate autoantigen with high prevalence in patients with transplant-associated coronary artery disease.
A HUVEC cDNA library was screened with sera from two patients who had developed transplant-associated coronary artery disease (TxCAD) following cardiac transplantation. A total of six positive clones were isolated from a primary screen of 40 000 genes. Subsequent DNA sequence analysis identified these to be lysyl tRNA synthetase, ribosomal protein L7, ribosomal protein L9, beta transducin and TANK. Another gene whose product could not be identified showed homology to a human cDNA clone (DKFZp566M063) derived from fetal kidney. Full-length constructs of selected genes were expressed as his-tag recombinant fusion proteins and used to screen a wider patient base by ELISA to determine prevalence and association with TxCAD. Of these ribosomal protein L7 showed the highest prevalence (55.6%) with TxCAD sera compared to 10% non-CAD.
No takes yet. Share an insight, caveat, or question.
Linke et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: